-+ 0.00%
-+ 0.00%
-+ 0.00%

Protagonist Therapeutics Announces $300M Buyback Plan

Benzinga·09/08/2026 20:07:00
Listen to the news

Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today announced that its Board of Directors has authorized a share repurchase program under which the Company may repurchase up to $300 million of its outstanding common stock.